Zydus Pharmaceuticals (USA) Inc recalls Estradiol Transdermal System
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Failed Impurities/Degradation Specifications.
- Products
-
- Estradiol Transdermal System
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- 21,360 units
- About this recall
- Estradiol Transdermal System, USP (Twice-Weekly) 0.0375mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1192-8